Aridis pharmaceuticals to present at the roth capital partners 2020 medtech innovation forum on a covid-19 panel

San jose, calif., oct. 27, 2020 /prnewswire/ -- aridis pharmaceuticals, inc. (nasdaq: ards), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, today announced the company will present at the roth...
ARDS Ratings Summary
ARDS Quant Ranking